ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,828Medicare Part D Prescriptions Filled, Including Refills

Rank: 86 out of 2170

$743K Total Retail Price of All Prescriptions

Rank: 184 out of 2170

574 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 13,551 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
METFORMIN HCL 652 476 1 8
OMEPRAZOLE 618 485 2 2
LISINOPRIL 615 508 3 3
ATENOLOL 552 470 4 23
FUROSEMIDE 483 413 5 6
SIMVASTATIN 465 366 6 1
AMLODIPINE BESYLATE 456 356 7 4
HYDROCHLOROTHIAZIDE 410 296 8 9
WARFARIN SODIUM 396 394 9 15
PRAVASTATIN SODIUM 326 293 10 11
ZOLPIDEM TARTRATE 323 282 11 17
TRAMADOL HCL 311 227 12 18
LEVOTHYROXINE SODIUM 293 222 13 5
METOPROLOL TARTRATE 286 258 14 10
SERTRALINE HCL 248 154 15 25
GABAPENTIN 239 163 16 14
BENAZEPRIL HCL 230 182 17 55
POTASSIUM CHLORIDE 221 194 18 16
MIRTAZAPINE 209 189 19 46
NEXIUM 205 135 20 22
LANTUS 198 144 21 51
MELOXICAM 188 129 22 28
ALLOPURINOL 183 156 23 29
ATORVASTATIN CALCIUM 182 134 24 12
CITALOPRAM HBR 181 145 25 19
LOSARTAN POTASSIUM 171 134 26 21
LOVASTATIN 170 128 27 34
HYDROCODONE-ACETAMINOPHEN 160 126 S3 28 7
GLIPIZIDE 147 136 29 62
DIOVAN 147 134 29 53
TAMSULOSIN HCL 116 88 31 33
FLUTICASONE PROPIONATE 114 85 32 30
TRAZODONE HCL 111 87 33 38
POLYETHYLENE GLYCOL 3350 102 98 34 63
ACTOS 101 72 35 108
CLONIDINE HCL 100 73 36 54
VERAPAMIL ER 99 86 37 94
GLIMEPIRIDE 97 95 38 31
CYCLOBENZAPRINE HCL 97 83 R 38 52
DIGOXIN 93 83 40 72
LOSARTAN-HYDROCHLOROTHIAZIDE 91 73 41 42
CYMBALTA 84 77 42 44
RISPERIDONE 82 80 43 73
ISOSORBIDE MONONITRATE ER 79 75 44 50
DONEPEZIL HCL 79 79 44 32
DILTIAZEM 24HR CD 78 76 46 82
ADVAIR DISKUS 77 61 47 45
METOLAZONE 77 61 47 210
INSULIN SYRINGE 75 50 49 113
METOPROLOL SUCCINATE 72 64 50 13
AMLODIPINE BESYLATE-BENAZEPRIL 72 63 50 67
PREDNISONE 71 52 52 41
SYNTHROID 70 51 53 27
DOXAZOSIN MESYLATE 70 70 53 93
METFORMIN HCL ER 68 59 55 35
VENLAFAXINE HCL ER 67 62 56 97
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 57 57 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 56 58 20
METOCLOPRAMIDE HCL 65 47 58 127
RAMIPRIL 65 51 58 77
CARVEDILOL 64 61 61 26
NYSTATIN 63 55 62 160
PANTOPRAZOLE SODIUM 62 52 63 39
RANITIDINE HCL 61 61 64 40
KLOR-CON M20 60 29 65 68
TRIAMCINOLONE ACETONIDE 59 31 66 128
ENALAPRIL MALEATE 58 44 67 64
PLAVIX 57 53 68 58
LIPITOR 56 53 69 83
PAROXETINE HCL 56 33 69 65
NOVOLOG 56 38 69 98
CLOPIDOGREL 54 49 72 37
OXYBUTYNIN CHLORIDE ER 53 38 73 148
PROAIR HFA 52 24 74 43
CIPROFLOXACIN HCL 52 43 74 69
PHENYTOIN SODIUM EXTENDED 51 32 76 142
BRIMONIDINE TARTRATE 51 35 76 278
IBUPROFEN 50 28 78 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.